>
Fa   |   Ar   |   En
   lipoglycopeptide antibiotics: reliable fighters against gram-positive pathogens  
   
نویسنده bagheri haleh ,sohrabi bahram ,salarian sara ,bagheri bahador
منبع archives of clinical infectious diseases - 2018 - دوره : 13 - شماره : 6 - صفحه:1 -5
چکیده    Multi-drug resistant (mdr) strains of staphylococci are usually difficult to treat. vancomycin has had a timehonored niche in treating mdr staphylococcus strains; however, during recent years, many clinical failures have been reported worldwide. since 2014, new semisynthetic lipoglycopeptides antibiotics have been introduced to combat methicillinresistant staphylococcus aureus (mrsa), vancomycinintermediate staphylococcus aureus (visa), vancomycinresistant staphylococcus aureus (vrsa), and vancomycinresistant enterococci (vre). they include dalbavancin, oritavancin, and telavancin. these semisynthetic lipoglycopeptides have a considerable efficacy against mdr staphylococcus strains. due to the presence of a lipid side chain, the halflife is prolonged and enables them to anchor the cell membrane of a pathogen. lipoglycopeptides display a greater potency and more consistent activity against all species of staphylococci than vancomycin. among them, oritavancin is active against mrsa, visa, and vrsa. however, dalbavancin and telavancin have activities against mrsa and visa. dalbavancin is used once weekly, telavancin is used daily, and oritavancin is usually administered one dose per treatment. compared to vancomycin, these semisynthetic lipoglycopeptides have longer halflives with a lower minimum inhibitory concentration (mic) and fast bactericidal activities. in addition, lipoglycopeptides have concentrationdependent effects in vivo and in vitro . in the present paper, we review the structure, mechanism of action, microbiology, indications, safety, and important interactions of dalbavancin, oritavancin, and telavancin.
کلیدواژه skin infections ,antibiotic ,lipoglycopeptide ,resistance
آدرس hospital center universitaire, faculty of medicine, department of pharmacology, france, tabriz university of medical sciences, department of cardiovascular diseases, ایران, shahid beheshti university of medical sciences, department of intensive care, ایران, semnan university of medical sciences, cancer research center, department of pharmacology, ایران
پست الکترونیکی bahadordvm@yahoo.com
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved